InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Aptevo Therapeutics Inc.

APVO Clue Score52
United States Fiscal year ends December CIK 0001671584
$1.79 -0.56% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.79 −87.63% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue10.0Operating income−138.8Net income−112.4Fiscal year 2017Revenue14.7 +46.8%Operating income−53.9Net income7.0Fiscal year 2018Revenue23.1 +57.4%Operating income−51.7Net income−53.7 −870.0%Fiscal year 2019Revenue32.4 +40.6%Operating income−41.0Net income−40.4Fiscal year 2020Revenue4.3 −86.7%Operating income−27.5Net income−17.8Fiscal year 2021Revenue12.3 +185.3%Operating income−21.4Net income−28.5EPS, diluted−6.07Fiscal year 2022Revenue3.1 −74.7%Operating income−28.6Net income8.0EPS, diluted1.57Fiscal year 2023Operating income−28.9Net income−17.4 −316.9%EPS, diluted−2,316.83Fiscal year 2024Operating income−24.6Net income−24.1EPS, diluted−31,460.23Fiscal year 2025Operating income−26.3Net income−26.0EPS, diluted−87.27
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 10.0 14.7 23.1 32.4 4.3 12.3 3.1 n/a n/a n/a
Growth +46.8% +57.4% +40.6% −86.7% +185.3% −74.7%
Operating income −138.8 −53.9 −51.7 −41.0 −27.5 −21.4 −28.6 −28.9 −24.6 −26.3
Net income −112.4 7.0 −53.7 −40.4 −17.8 −28.5 8.0 −17.4 −24.1 −26.0
Growth −870.0% −316.9%
EPS, diluted n/a n/a n/a n/a n/a −6.07 1.57 −2,316.83 −31,460.23 −87.27

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,389.8%Net margin−1,125.8%Free cash flow margin−394.3%Fiscal year 2017Operating margin−368.1%Net margin47.6%Free cash flow margin−293.2%Fiscal year 2018Operating margin−224.0%Net margin−232.8%Free cash flow margin−227.2%Fiscal year 2019Operating margin−126.3%Net margin−124.7%Free cash flow margin−131.2%Fiscal year 2020Operating margin−638.1%Net margin−411.9%Free cash flow margin−682.4%Fiscal year 2021Operating margin−174.1%Net margin−231.5%Free cash flow margin−182.2%Fiscal year 2022Operating margin−919.7%Net margin257.8%Free cash flow margin−676.0%Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,389.8% −368.1% −224.0% −126.3% −638.1% −174.1% −919.7% n/a n/a n/a
Net margin −1,125.8% 47.6% −232.8% −124.7% −411.9% −231.5% 257.8% n/a n/a n/a
Free cash flow margin −394.3% −293.2% −227.2% −131.2% −682.4% −182.2% −676.0% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−36.9Capital expenditure−2.5Free cash flow−39.4Fiscal year 2017Operating cash flow−41.6Capital expenditure−1.4Free cash flow−43.0Fiscal year 2018Operating cash flow−51.4Capital expenditure−1.0Free cash flow−52.4Fiscal year 2019Operating cash flow−42.4Capital expenditure−0.2Free cash flow−42.5Fiscal year 2020Operating cash flow−29.3Capital expenditure−0.1Free cash flow−29.4Fiscal year 2021Operating cash flow−21.7Capital expenditure−0.7Free cash flow−22.4Fiscal year 2022Operating cash flow−21.0Capital expenditure−0.0Free cash flow−21.1Fiscal year 2023Operating cash flow−11.7Fiscal year 2024Operating cash flow−23.8Fiscal year 2025Operating cash flow−25.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −36.9 −41.6 −51.4 −42.4 −29.3 −21.7 −21.0 −11.7 −23.8 −25.6
Capital expenditure −2.5 −1.4 −1.0 −0.2 −0.1 −0.7 −0.0 n/a n/a n/a
Free cash flow −39.4 −43.0 −52.4 −42.5 −29.4 −22.4 −21.1 n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash9.7Total debt18.4Net cash (debt)−8.7Shareholders’ equity50.6Debt to equity0.36Fiscal year 2017Cash7.1Total debt19.1Net cash (debt)−12.0Shareholders’ equity82.0Debt to equity0.23Fiscal year 2018Cash30.6Total debt19.3Net cash (debt)11.4Shareholders’ equity30.4Debt to equity0.63Fiscal year 2019Cash12.4Total debt19.9Net cash (debt)−7.4Shareholders’ equity11.8Debt to equity1.68Fiscal year 2020Cash40.0Total debt33.2Net cash (debt)6.8Shareholders’ equity16.6Debt to equity2.00Fiscal year 2021Cash45.0Total debt15.4Net cash (debt)29.7Shareholders’ equity1.2Debt to equity12.64Fiscal year 2022Cash22.6Total debt3.5Net cash (debt)19.2Shareholders’ equity18.0Debt to equity0.19Fiscal year 2023Cash16.9Total debt0.0Net cash (debt)16.9Shareholders’ equity12.2Debt to equity0.00Fiscal year 2024Cash8.7Shareholders’ equity4.8Fiscal year 2025Cash21.6Shareholders’ equity17.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 9.7 7.1 30.6 12.4 40.0 45.0 22.6 16.9 8.7 21.6
Total debt 18.4 19.1 19.3 19.9 33.2 15.4 3.5 0.0 n/a n/a
Net cash (debt) −8.7 −12.0 11.4 −7.4 6.8 29.7 19.2 16.9 n/a n/a
Shareholders’ equity 50.6 82.0 30.4 11.8 16.6 1.2 18.0 12.2 4.8 17.4
Debt to equity 0.36 0.23 0.63 1.68 2.00 12.64 0.19 0.00 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
10.0 14.7 23.1 32.4 4.3 12.3 3.1 n/a n/a n/a
Growth +46.8% +57.4% +40.6% −86.7% +185.3% −74.7%
n/a n/a 11.2 19.9 n/a n/a n/a n/a n/a n/a
29.1 29.0 35.4 24.8 17.9 19.0 17.9 17.1 14.4 14.5
36.2 34.6 28.1 25.3 14.0 14.7 13.9 11.8 10.2 11.8
−138.8 −53.9 −51.7 −41.0 −27.5 −21.4 −28.6 −28.9 −24.6 −26.3
Growth
−139.6 −55.9 −53.7 −43.1 −30.9 −29.4 7.0 −18.7 −24.1 −26.0
−19.7 −23.3 n/a n/a n/a n/a n/a n/a n/a 0.0
−112.4 7.0 −53.7 −40.4 −17.8 −28.5 8.0 −17.4 −24.1 −26.0
Growth −870.0% −316.9%
Per share
n/a n/a n/a n/a n/a −6.07 1.57 −2,316.83 −31,460.23 −87.27
n/a n/a n/a n/a n/a −6.07 1.57 −2,316.83 −31,460.23 −87.27
Growth −147,668.8%
n/a n/a n/a n/a n/a 4.7 5.1 0.0 0.0 0.3
n/a n/a n/a n/a n/a 4.7 5.1 0.0 0.0 0.3
Growth +8.9% −99.9% −89.8% +41,038.9%

† The diluted share count jumps at 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 26.6% a year over five years.
  • Operating margin is down 551.7 points on five years ago, at -919.7%.
  • A net loss in 8 of 10 years on file.